Press Release

Nanochon cultivate(MD) news

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

August 14, 2026 – Nanochon, a cultivate(MD) portfolio company developing Chondrograftâ„¢, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance […]

Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™ Read More »

Shoulder Innovations a cultivate(MD) portfolio company

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Generates First Half 2026 Revenue Growth of 60% Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the first quarter ended June 30, 2026. Second Quarter Financial Highlights Recent Business Highlights “Our second quarter results build on a strong start to the year and reflect remarkable momentum across every dimension of

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook Read More »

SpinTech MRI cultivate(MD) news

SpinTech MRI Appoints Brian Martin as Chief Executive Officer to Lead Next Phase of Commercial Growth

Experienced medical technology executive to accelerate commercialization, strategic partnerships, and market expansion following successful financing and strong company foundation. BINGHAM FARMS, MI – July 23, 2026 – SpinTech MRI, a leader in advanced quantitative magnetic resonance imaging (MRI) post-processing software, today announced the appointment of Brian Martin as Chief Executive Officer. Martin, an accomplished medical

SpinTech MRI Appoints Brian Martin as Chief Executive Officer to Lead Next Phase of Commercial Growth Read More »

Shoulder Innovations a cultivate(MD) portfolio company

Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook

Generates First Quarter Net Revenue Growth of 65% Year-Over-Year Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the first quarter ended March 31, 2026. First Quarter Financial Highlights Recent Business Highlights “We are very pleased with our first quarter performance, which reflects accelerating revenue growth and intensifying commercial momentum across

Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook Read More »

cultivate(MD) Focus Fund news

cultivate(MD) Focus Fund Announces Initial Capital Deployments

The Focus Fund is cultivate(MD)’s fifth vehicle: a 2031-horizon strategy to identify, support, and exit best-in-class early-stage medical device companies. GRAND RAPIDS, Mich., May 11, 2026 — cultivate(MD), a leading medical device venture capital company, announced that its Focus Fund has deployed capital across four portfolio companies over the past month. THIS PRESS RELEASE IS

cultivate(MD) Focus Fund Announces Initial Capital Deployments Read More »

Prana Surgical cultivate(MD)

Prana Surgical Announces the Prana Systemâ„¢ Receives FDA Clearance

Image-guided platform enables minimally invasive, tissue-sparing excision. HOUSTON, April 2, 2026 /PRNewswire-PRWeb/ — Prana Surgical, a Houston-based medical device company, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for the Prana Systemâ„¢, an electrosurgical device indicated to remove tissue and control bleeding. The Prana System is a sterile, single-use electrosurgical

Prana Surgical Announces the Prana System™ Receives FDA Clearance Read More »